Published in Lancet on June 05, 2014
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV (2015) 1.62
The Uptake of Prevention of Mother-to-Child HIV Transmission Programs in China: A Systematic Review and Meta-Analysis. PLoS One (2015) 1.39
Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? Viruses (2015) 1.07
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology (2015) 1.06
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe (2016) 1.04
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA. Mol Cell (2016) 1.03
The Sordid Affair Between Human Herpesvirus and HIV. J Infect Dis (2015) 1.02
Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care (2015) 0.97
A Framework for Health Communication Across the HIV Treatment Continuum. J Acquir Immune Defic Syndr (2017) 0.96
Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care. Trop Med Int Health (2015) 0.96
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J (2016) 0.94
The virome in host health and disease. Immunity (2015) 0.92
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat Biotechnol (2016) 0.90
Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children. Biomed Res Int (2015) 0.88
Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney. J Int AIDS Soc (2015) 0.88
Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy. Curr Trop Med Rep (2015) 0.87
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep (2016) 0.85
Rapid HIV Testing Is Highly Acceptable and Preferred among High-Risk Gay And Bisexual Men after Implementation in Sydney Sexual Health Clinics. PLoS One (2015) 0.84
Reluctance to care for patients with HIV or hepatitis B / C in Japan. BMC Pregnancy Childbirth (2016) 0.83
Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy. Open AIDS J (2014) 0.83
HIV and HCV Medications in End-Stage Renal Disease. Semin Dial (2015) 0.82
Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. PLoS One (2015) 0.81
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies. Mol Ther Methods Clin Dev (2016) 0.80
Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection. Mucosal Immunol (2015) 0.80
Virus-based nanoparticles as platform technologies for modern vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.80
Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells. Alcohol Clin Exp Res (2015) 0.79
A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection. AIDS (2015) 0.79
FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency. J Biol Chem (2015) 0.79
Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers. PLoS Pathog (2016) 0.78
Transcriptomic Analysis of mRNAs in Human Monocytic Cells Expressing the HIV-1 Nef Protein and Their Exosomes. Biomed Res Int (2015) 0.78
Seminal Shedding of CMV and HIV Transmission among Men Who Have Sex with Men. Int J Environ Res Public Health (2015) 0.78
Comparisons of Adherence to Antiretroviral Therapy in a High- Risk Population in China: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.78
Communicable and non-communicable diseases: connections, synergies and benefits of integrating care. Public Health Action (2015) 0.78
CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data. Front Microbiol (2015) 0.78
The gut microbiome in human immunodeficiency virus infection. BMC Med (2016) 0.78
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site. J Antimicrob Chemother (2016) 0.78
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77
Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success? J Int AIDS Soc (2015) 0.77
Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy. AIDS (2016) 0.77
Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity. J Virol (2015) 0.77
HIV eradication: combinatorial approaches to activate latent viruses. Viruses (2014) 0.77
A novel multiplex isothermal amplification method for rapid detection and identification of viruses. Sci Rep (2015) 0.77
Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection. PLoS Pathog (2016) 0.76
Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed Res Int (2015) 0.76
Knowledge, Attitudes, Practices and Beliefs about Medical Male Circumcision (MMC) among a Sample of Health Care Providers in Haiti. PLoS One (2015) 0.75
Ethical implications of HIV self-testing: the game is far from being over. Pan Afr Med J (2016) 0.75
Crystal structure of ethyl 2,4-di-chloro-quinoline-3-carboxyl-ate. Acta Crystallogr E Crystallogr Commun (2015) 0.75
HIV Diagnosis and Treatment through Advanced Technologies. Front Public Health (2017) 0.75
Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence. Open Forum Infect Dis (2016) 0.75
Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain. PLoS One (2016) 0.75
Untangling the Gordian knot of HIV, stress, and cognitive impairment. Neurobiol Stress (2016) 0.75
Uniquely altered transcripts are associated with immune preservation in HIV infection. PLoS One (2017) 0.75
HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response. Expert Rev Vaccines (2016) 0.75
Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests. AIDS Res Ther (2016) 0.75
Immunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2). Genes Immun (2015) 0.75
Periportal fibrosis, liver and spleen sizes among S. mansoni mono or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania. Parasit Vectors (2015) 0.75
A 10 years audit of cardiothoracic referrals from a pulmonology service in a developing country: impact of patient human immunodeficiency virus status. Ann Transl Med (2016) 0.75
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty (2017) 0.75
Ethical issues surrounding the provider initiated opt--Out prenatal HIV screening practice in Sub-Saharan Africa: a literature review. BMC Med Ethics (2015) 0.75
Estimation of the Undiagnosed Intervals of HIV-Infected Individuals by a Modified Back-Calculation Method for Reconstructing the Epidemic Curves. PLoS One (2016) 0.75
Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. J Int AIDS Soc (2016) 0.75
Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients. BMC Res Notes (2017) 0.75
Recent Insights into the HIV/AIDS Pandemic. Microb Cell (2016) 0.75
Opioids and Viral Infections: A Double-Edged Sword. Front Microbiol (2016) 0.75
Impact of a primary care national policy on HIV screening in France: a longitudinal analysis between 2006 and 2013. Br J Gen Pract (2016) 0.75
HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes. PLoS One (2017) 0.75
Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark. BMC Infect Dis (2016) 0.75
Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy. World J Virol (2015) 0.75
Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies. J Med Ethics (2017) 0.75
Does cerumen have a risk for transmission of HIV? Eur J Clin Microbiol Infect Dis (2014) 0.75
Application of nanodiagnostics in point-of-care tests for infectious diseases. Int J Nanomedicine (2017) 0.75
UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on "Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades". BMJ Glob Health (2017) 0.75
The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther (2017) 0.75
Causal role of infectious agents in cancer: An overview. Caspian J Intern Med (2017) 0.75
The Pharmacokinetic Interaction between Ivacaftor and Ritonavir in Healthy Volunteers. Br J Clin Pharmacol (2017) 0.75